Trajectories of Kidney Function in Autosomal Dominant Polycystic Kidney Disease Patients Treated with Tolvaptan. [PDF]
Jankowska Z, Niemczyk M.
europepmc +1 more source
Pentosidine and Bone Properties in Autosomal Dominant Polycystic Kidney Disease. [PDF]
Jankowska M +8 more
europepmc +1 more source
Congenital Hepatic Fibrosis and/or Autosomal Recessive Polycystic Kidney Disease: A Single-center Experience. [PDF]
Altay D, Yel S, Dursun İ, Arslan D.
europepmc +1 more source
GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease. [PDF]
Srivastava C +8 more
europepmc +1 more source
Retroperitoneoscopic Nephrectomy at the Time of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: Safety, Efficacy, Feasibility, and Cosmetic Outcomes. [PDF]
Ohyama T +4 more
europepmc +1 more source
Mechanistic Insights into the Pathogenesis of Polycystic Kidney Disease. [PDF]
Al-Orjani Q +5 more
europepmc +1 more source
Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease. [PDF]
Lanktree MB +18 more
europepmc +1 more source
Autosomal dominant polycystic kidney disease is not a risk factor for scoliosis. [PDF]
Jankowska Z, Niemczyk M.
europepmc +1 more source
EGR1 Nuclear Condensates Promote Renal Cyst Development in Polycystic Kidney Disease. [PDF]
Ren C +15 more
europepmc +1 more source
Natural history of simple and complex cysts in autosomal dominant polycystic kidney disease on MRI. [PDF]
Hu Z, Li C, Blumenfeld JD, Prince MR.
europepmc +1 more source

